Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine
AbstractTo evaluate the effectiveness of hepatitis B virus [HBV] vaccination of household contacts of HBV carriers in Tulkarm district, Palestine, quantitative hepatitis B surface [anti-HBs] antibody response in 161 household contacts was measured after vaccination. A seroprotective anti-HBs response [titre > or = 10 IU/L] was elicited in all vaccinated subjects. Of these 2.5% had titres of 10-99 IU/L, 61.5% 100-999 IU/L and 36.0% > or = 1000 IU/L.The number of vaccination doses had no effect on the achievement of seroprotection. HBV infection was demonstrated in 13 cases and their anti-HBV titres were in the range 25-350 IU/L
Adwan, K., Abu Hasan, N., Adwan, G. & Abu Khater, K. (2005). Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine. EMHJ - Eastern Mediterranean Health Journal, 11 (3), 494-498, 2005 https://apps.who.int/iris/handle/10665/116972
JournalEMHJ - Eastern Mediterranean Health Journal, 11 (3), 494-498, 2005
MetadataShow full item record
Showing items related by title and subject
Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan Rehman, A.; Mazhar, A.; Sheikh, M.A.; Naeem, M.M.; Bhatti, A. (2012)Screening of blood reduces but does not eliminate the risk of hepatitis B virus [HBV] infection in multi-transfused thalassaemia patients. This study was done to evaluate efficacy of HBV vaccination on hepatitis B virus ...
Morsi, M.G.; Zaki, S.A.; Kamal, M.K.; Sadaka, S.A.; El Shimy, Y.M. (1997)Immunological studies among jaundiced patients revealed significant changes in T-helper and T-suppressor cells among chronic HBV cases from the acute and control groups. The chronic cases revealed a highly significant ...
Mycobacterial heat-shock proteins as carrier molecules / C. Barrios ... [et al.]. II., The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guerin priming Barrios, C; Lussow, A. R; Embden, J. van; Zee, R. van der; Rappuoli, R; Costantino, P; Louis, J. A; Lambert, P. H; Del Giudice, G (1992)